Frontiers in Psychiatry,
Journal Year:
2024,
Volume and Issue:
14
Published: Jan. 9, 2024
Introduction
Older
patients
are
frequently
affected
by
infectious
diseases
and
adverse
drug
reactions
(ADRs)
of
consecutively
prescribed
antibiotics.
Particularly
within
geriatric
psychiatry,
high
rates
potentially
inappropriate
prescriptions
(PIPs)
have
been
described,
significantly
complicating
pharmacological
treatment.
Therefore,
this
study
aimed
to
investigate
the
frequency
characteristics
antibiotic
PIPs
in
psychiatry.
Methods
Medication
charts
139
patient
cases
(mean
age
78.8
years;
69.8%
female)
receiving
treatment
on
a
psychiatric
ward
were
analyzed.
Utilizing
previously
published
definitions
PIPs,
adequacy
was
subsequently
assessed.
Results
16.3%
all
screened
(139/851)
received
an
during
their
inpatient
stay.
59.5%
due
urinary
tract
infections,
followed
pulmonary
(13.3%)
skin
soft
tissue
infections
(11.3%).
46.7%
fulfilled
at
least
one
PIP
criterium,
with
prescription
course
for
more
than
seven
days
as
most
common
(15.3%).
Discussion
Antibiotic
can
be
considered
frequent
phenomenon
Especially
use
fluoroquinolones
cephalosporins
should
discussed
critically
extensive
side
effect
profiles.
Due
special
patients,
international
guidelines
antibiotics
consider
frailty
psychotropic
polypharmacy
population
closely.
Annals of Intensive Care,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Jan. 10, 2024
Abstract
Sepsis
is
a
significant
public
health
concern,
particularly
affecting
individuals
above
70
years
in
developed
countries.
This
crucial
fact
due
to
the
increasing
aging
population,
their
heightened
vulnerability
sepsis,
and
associated
high
mortality
rates.
However,
morbidity
long-term
outcomes
are
even
more
notable.
While
many
patients
respond
well
timely
appropriate
interventions,
it
imperative
enhance
efforts
identifying,
documenting,
preventing,
treating
sepsis.
Managing
sepsis
older
poses
greater
challenges
necessitates
comprehensive
understanding
of
predisposing
factors
suspicion
for
diagnosing
infections
assessing
risk
sudden
deterioration
into
Despite
age
often
being
considered
an
independent
factor
morbidity,
recent
research
emphasizes
pivotal
roles
frailty,
disease
severity,
comorbid
conditions
influencing
outcomes.
In
addition,
important
inquire
about
patient's
preferences
establish
personalized
treatment
plan
that
considers
potential
recovery
with
quality
life
functional
review
provides
summary
most
aspects
consider
when
dealing
old
critically
ill
patient
Microorganisms,
Journal Year:
2024,
Volume and Issue:
12(10), P. 1978 - 1978
Published: Sept. 30, 2024
Antibiotic
resistance
presents
a
critical
challenge
in
healthcare,
particularly
among
the
elderly,
where
multidrug-resistant
organisms
(MDROs)
contribute
to
increased
morbidity,
mortality,
and
healthcare
costs.
This
review
focuses
on
mechanisms
underlying
key
bacterial
pathogens
highlights
how
aging-related
factors
like
immunosenescence,
frailty,
multimorbidity
increase
burden
of
infections
from
MDROs
this
population.
Novel
strategies
mitigate
include
development
next-generation
antibiotics
teixobactin
cefiderocol,
innovative
therapies
such
as
bacteriophage
therapy
antivirulence
treatments,
implementation
antimicrobial
stewardship
programs
optimize
antibiotic
use.
Furthermore,
advanced
molecular
diagnostic
techniques,
including
nucleic
acid
amplification
tests
sequencing,
allow
for
faster
more
precise
identification
resistant
pathogens.
Vaccine
development,
through
approaches
multi-epitope
vaccines
nanoparticle-based
platforms,
holds
promise
preventing
MDRO
elderly.
The
role
machine
learning
(ML)
predicting
patterns
aiding
vaccine
is
also
explored,
offering
promising
solutions
personalized
treatment
prevention
By
integrating
cutting-edge
diagnostics,
therapeutic
innovations,
ML-based
approaches,
underscores
importance
multidisciplinary
efforts
address
global
aging
populations.
Therapeutic Advances in Drug Safety,
Journal Year:
2025,
Volume and Issue:
16
Published: Jan. 1, 2025
Background:
Clarithromycin
is
a
widely
used
antibiotic,
but
its
safety
profile,
particularly
in
different
age
groups,
remains
inadequately
explored.
Objectives:
This
study
aims
to
characterize
and
illustrate
the
features
of
clarithromycin-related
adverse
events
(AEs)
across
groups
using
FDA
Adverse
Event
Reporting
System
(FAERS)
database,
providing
reference
for
clinical
detection,
prevention,
management
AEs
various
groups.
Design:
A
disproportionality
analysis
was
performed
data
from
FAERS
database.
The
included
all
AE
reports
related
clarithromycin,
stratified
by
Methods:
Disproportionality
conducted
reporting
odds
ratio,
proportional
Bayesian
confidence
propagation
neural
network,
multiple
gamma
Poisson
shrinkers.
Statistical
analyses
descriptive
statistics
Chi-square
tests.
Results:
total
7319
clarithromycin
were
retrieved
Vomiting,
diarrhea,
drug
interactions,
interactions
reported
most
frequently
0–17,
18–44,
45–64,
⩾65
years,
respectively.
Abnormal
product
taste,
taste
disorder,
medication
errors
specified
package
insert
strongest
signals
41
Preferred
Terms
not
explicitly
mainly
associated
with
psychiatric
disorders,
skin
subcutaneous
tissue
gastrointestinal
among
others.
Specific
differences
identified,
18
being
age-specific,
including
3
children
15
elderly
individuals.
Conclusion:
profile
varies
In
children,
it
vomiting,
hypersensitivity,
dyspnea,
while
adults,
are
more
common.
elderly,
should
be
cautiously,
attention
interactions.
Microorganisms,
Journal Year:
2025,
Volume and Issue:
13(1), P. 136 - 136
Published: Jan. 10, 2025
A
comprehensive
pharmacovigilance
surveillance
on
antibacterials
is
lacking.
This
study
aims
to
investigate
safety
signals
of
antibacterial-related
adverse
drug
events
(ADEs)
with
seriousness
and
identify
predictors
serious
ADEs.
investigated
52,503
antibacterial-induced
ADEs
reported
the
Korea
Adverse
Event
Reporting
System
Database
from
January
2013
December
2022.
Disproportionality
analysis
was
conducted,
effect
sizes
were
estimated
by
reporting
odds
ratios
(ROR),
proportional
ratio
(PRR),
information
component
(IC).
Multivariate
logistic
regression
performed
estimating
(OR).
Serious
more
likely
be
cardiovascular
disorders
(ROR
6.77,
PRR
6.6,
IC
2.37),
urinary
system
5.56,
5.22,
2.12),
platelet,
bleeding,
clotting
5.41,
5.17,
2.06).
The
may
include
age
(OR
1.05),
number
concomitant
medications
1.44),
proton
pump
inhibitors
1.46)
non-steroidal
anti-inflammatory
drugs
1.38)
use,
specific
antibacterial
classes,
while
multiple
therapy
associated
lower
ADE
risks.
sensitivity
also
suggests
male
sex
1.18)
as
a
potential
predictor
However,
further
studies
are
imperative
determine
causality
in
critically
ill
patients.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: April 2, 2024
Abstract
It
is
becoming
increasingly
evident
that
the
myriad
of
microbes
in
gut,
within
cells
and
attached
to
body
parts
(or
roots
plants),
play
crucial
roles
for
host.
Although
this
has
been
known
decades,
recent
developments
molecular
biology
allow
expanded
insight
into
abundance
function
these
microbes.
Here
we
used
vinegar
fly,
Drosophila
melanogaster
,
investigate
fitness
measures
across
lifetime
flies
fed
a
suspension
gut
harvested
from
young
or
old
flies,
respectively.
Our
hypothesis
was
constitutively
enriched
with
‘Young
microbiome’
would
live
longer
be
more
agile
at
age
(i.e.
have
increased
healthspan)
compared
an
‘Old
microbiome’.
Three
major
take
home
messages
came
out
our
study:
(1)
microbiomes
differ
markedly;
(2)
feeding
Young
Old
altered
microbiome
recipient
(3)
two
different
microbial
diets
did
not
any
effect
on
locomotor
activity
nor
lifespan
contradicting
working
hypothesis.
Combined,
results
provide
novel
interplay
between
hosts
their
clearly
highlight
phenotypic
effects
transplants
probiotics
can
complex
unpredictable.
Frontiers in Medicine,
Journal Year:
2024,
Volume and Issue:
11
Published: July 11, 2024
Chronic
kidney
disease
(CKD)
in
older
individuals
is
a
matter
of
growing
concern
the
field
public
health
across
globe.
Indeed,
prevalence
function
impairment
increases
with
advancing
age
and
often
exacerbated
by
age-induced
modifications
function,
presence
chronic
diseases
such
as
diabetes,
hypertension,
cardiovascular
disorders,
increased
burden
related
to
frailty,
cognitive
sarcopenia.
Accurate
assessment
CKD
crucial
for
timely
intervention
management
relies
heavily
on
biomarkers
diagnosis
monitoring.
However,
interpretation
these
patients
may
be
complex
due
interplays
between
CKD,
aging,
geriatric
syndromes.
Biomarkers
serum
creatinine,
estimated
glomerular
filtration
rate
(eGFR),
albuminuria
can
significantly
altered
systemic
inflammation,
metabolic
changes,
medication
use
commonly
seen
this
population.
To
overcome
limitations
traditional
biomarkers,
several
innovative
proteins
have
been
investigated
potential,
review
we
aimed
at
consolidating
existing
data
concerning
aspects
describing
challenges
considerations
using
assess
patients,
highlighting
need
integration
clinical
context
improve
biomarkers’
accuracy.
Clinical Pharmacokinetics,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 11, 2025
As
people
age,
the
efficiency
of
various
regulatory
processes
that
ensure
proper
communication
between
cells
and
organs
tends
to
decline.
This
deterioration
can
lead
difficulties
in
maintaining
homeostasis
during
physiological
stress.
includes
but
is
not
limited
cognitive
impairments,
functional
difficulties,
issues
related
caregivers
which
contribute
significantly
medication
errors
non-adherence.
These
factors
higher
morbidity,
extended
hospital
stays,
reduced
quality
life,
even
mortality.
The
decrease
homeostatic
capacity
varies
among
individuals,
contributing
greater
variability
observed
geriatric
populations.
Significant
pharmacokinetic
pharmacodynamic
alterations
accompany
ageing.
Pharmacokinetic
changes
include
decreased
renal
hepatic
clearance
an
increased
volume
distribution
for
lipid-soluble
drugs,
prolong
their
elimination
half-life.
Pharmacodynamic
typically
involve
sensitivity
drug
classes,
such
as
anticoagulants,
antidiabetic
psychotropic
medications.
review
examines
primary
age-related
geriatrics
impact
on
pharmacokinetics
pharmacodynamics
Helicobacter,
Journal Year:
2025,
Volume and Issue:
30(1)
Published: Jan. 1, 2025
ABSTRACT
Helicobacter
pylori
is
prevalent
globally
and
implicated
in
various
gastric
diseases
malignancies.
Rising
antibiotic
resistance
has
increasingly
compromised
the
effectiveness
of
standard
H.
eradication
therapies.
This
review
explores
role
antimicrobial
stewardship
(AMS)
as
a
structured
approach
to
optimizing
management
through
“5D”
strategy:
Diagnosis—utilizing
advanced
diagnostic
tools
accurately
detect
bacterial
resistance;
Drug—selecting
antibiotics
tailored
profiles
patient‐specific
factors;
Dosage—optimizing
dosing
frequency
based
on
pharmacokinetic
properties
maximize
efficacy;
Duration—employing
shorter
treatment
courses
where
supported
by
evidence;
Discontinuation—balancing
benefits
risks
repeated
treatments.
We
discuss
recent
advances
technologies,
such
polymerase
chain
reaction
next‐generation
sequencing,
their
impact
therapeutic
decision‐making.
Additionally,
we
evaluate
regimens,
with
particular
focus
emerging
alternatives
regimens
containing
potassium‐competitive
acid
blockers.
Given
growing
global
limited
pipeline
for
new
antibiotics,
advocate
more
strategic
resource‐conscious
management,
integrating
AMS
principles
within
“One
Health”
framework
address
pathogen's
transmission
across
humans,
animals,
environment.
With
advancements
testing
diagnostics,
therapies
are
likely
become
personalized
precise.
To
achieve
this,
effective
implementation
necessitates
interdisciplinary
collaboration
outcomes,
minimize
adverse
effects,
combat
resistance,
reduce
healthcare
costs.